Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Diabetic Peripheral Neuropathic Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

155

Participants

Timeline

Start Date

January 26, 2022

Primary Completion Date

October 13, 2022

Study Completion Date

October 13, 2022

Conditions
Diabetic Peripheral Neuropathic Pain
Interventions
DRUG

LY3526318

Administered orally

DRUG

Placebo

Administered orally

Trial Locations (37)

16635

Altoona Center For Clinical Research, Duncansville

30189

North Georgia Clinical Research, Woodstock

32162

Synexus Clinical Research US, Inc - Orlando, The Villages

32806

Synexus Clinical Research US, Inc - Orlando, Orlando

33135

Suncoast Research Group, Miami

33136

University of Miami Don Suffer Clinical Research Building, Miami

33165

New Horizon Research Center, Miami

33180

VIN-Julie Schwartzbard, Aventura

33781

Synexus Clinical Research US, Inc., Pinellas Park

34470

Renstar Medical Research, Ocala

45236

Synexus - Cincinnati, Cincinnati

45432

META Medical Research Institute, Dayton

48706

Great Lakes Research Group, Inc., Bay City

60077

NorthShore University HealthSystem, Skokie

60602

Synexus Clinical Research US, Inc., Chicago

60611

Northwestern University, Chicago

63303

StudyMetrix Research, City of Saint Peters

65807

Clinvest Research LLC, Springfield

75251

Cedar Health Research, Dallas

78229

Synexus - US, San Antonio

78731

FutureSearch Trials, Austin

83404

Rocky Mountain Clinical Research, Idaho Falls

85053

Arizona Research Center, Phoenix

85224

Synexus Clinical Research US, Inc., Chandler

85281

Alliance for Multispecialty Research, LLC Tempe, Tempe

85306

Synexus Clinical Research - Glendale, Glendale

92103

Artemis Institute for Clinical Research, San Diego

92503

Artemis Institute for Clinical Research, Riverside

98007

Northwest Clinical Research Center, Bellevue

98057

Rainier Clinical Research Center, Renton

06517

CMR of Greater New Haven, Hamden

02131

Boston Clinical Trials, Boston

02215

Joslin Diabetes Center, Boston

01844

ActivMed Practices and Research, Methuen

02451

MedVadis Research Corporation, Waltham

00716

Ponce Medical School Foundation Inc., Ponce

00909

Latin Clinical Trial Center, San Juan

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY